Psychedelics Psychedelic drug developer MindMed set for listing on Nasdaq Biotechnology Index MindMed's lead drug candidate is an LSD-like therapeutic used to treat anxiety Rowan DunneDecember 20, 2024
Legalization Georgia advances bill to create psychedelic study group focused on Veterans’ mental health Lawmakers note that current therapeutic trials for substance use issues exclude people with a history of substance abuse Natalia Buendia CalvilloMarch 29, 2022
News Psilocybin therapy for major depression can relieve symptoms for a year: study The long-term benefits contrast with the more temporary effects of conventional antidepressants Natalia Buendia CalvilloFebruary 18, 2022